Tarasaponin IV, as an oleanane-type triterpene saponin, is isolated from the bark of Aralia elata. Tarasaponin IV can be used for the research of cancer.

Tarasaponin IV (0.1~10 μM; 1 hour; HepG2 cells) shows that the inhibitory effects on NF-κB transcriptional activation in HepG2 cells stimulated with TNFα[1].

156980-31-3

C53H84O23

1089.232

Tarasaponin IV

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years